chronic obstructive pulmonary disease

Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections

Cefodizime is a third–generation cephalosporin for parenteral use that has become available for the first time in the Russia. This paper reviews the use of this antibiotic in clinical practice based on the current data on antimicrobial resistance in …

Oral third-generation cephalosporin cefpodoxime in the therapy of respiratory infections

Oral 3rd generation cephalosporin cefpodoxime proxetil has been available in the antibiotic armamentarium for more than 30 years, however, unlike other oral cephalosporins (e.g. cefixime), it has not been given due recognition in clinical practice in …

Microbiota in the pathogenesis of COPD and its impact on the course of the disease

Chronic obstructive pulmonary disease (COPD) is a serious problem for global health. Infectious agents play a main role in the development of COPD exacerbations. Bacterial colonization of the lower respiratory tract is common in patients with stable …

Antibacterial Therapy of Infectious Exacerbations of Chronic Bronchitis: from Pathogen Eradication to Long-Term Relapse-Free Period

Chronic obstructive pulmonary disease (COPD) is a chronic illness that is characterized by recurring exacerbations. Exacerbations lead to the progression of the disease with development of respiratory failure, decreasing of the quality of life of the …

The Role of Chlamydophila pneumoniae in the Human Bronchopulmonary Diseases

So-called atypical respiratory pathogens in general and Chlamydophila pneumoniae in particular, are now well recognized as a common cause of acute upper and lower respiratory-tract infections, especially communityacquired pneumonia. Furthermore C. …